Table 1:
Patient-level clinical and demographic characteristics, by IPT completion status
| Baseline Variables | Completed IPT (N=732) |
Did Not Complete IPT (N=242) |
Total (N=974) |
P-value |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Age Category | ||||
| 18–25 | 132 (18.0) | 72 (29.8) | 204 (20.9) | 0.001 |
| 26–35 | 296 (40.4) | 87 (36.0) | 383 (39.3) | |
| 36–45 | 204 (27.9) | 58 (24.0) | 262 (26.9) | |
| >45 | 100 (13.7) | 25 (10.3) | 125 (12.8) | |
| Sex/Pregnancy Status | ||||
| Pregnant female | 151 (20.6) | 60 (28.4) | 211 (21.7) | 0.133 |
| Non-pregnant female | 343 (46.9) | 96 (39.7) | 439 (45.1) | |
| Male | 238 (32.5) | 86 (35.5) | 324 (33.3) | |
| Self-Reported Health | ||||
| Excellent | 100 (13.7) | 31 (12.8) | 131 (13.5) | 0.827 |
| Good | 368 (50.3) | 125 (51.7) | 493 (50.6) | |
| Fair | 225 (30.7) | 70 (28.9) | 295 (30.3) | |
| Poor | 39 (5.3) | 16 (6.6) | 55 (5.7) | |
| WHO HIV Stage* | ||||
| 1 or 2 | 599 (82.4) | 195 (81.3) | 794 (82.1) | 0.689 |
| 3 or 4 | 128 (17.6) | 45 (18.8) | 173 (17.9) | |
| Previous History of TB | 10 (1.4) | 3 (1.2) | 13 (1.3) | 1.0‡ |
| Any TB Symptoms at Enrollment | 164 (22.4) | 40 (16.5) | 204 (20.9) | 0.052 |
| Concurrent ART Exposure | 122 (16.7) | 30 (12.4) | 152 (15.6) | 0.113 |
| Eligible for ART at Enrollment | 355 (48.8) | 117 (48.8) | 472 (48.8) | 0.983 |
| Number of Follow-Up Visits (Median, IQR) | 6 (5–7) | 1 (0–3) | 6 (4–7) | <0.001 |
| Experienced IPT Side-Effects during Follow-Up | 6 (0.8) | 3 (1.7) | 9 (1.0) | 0.389‡ |
| Hospitalized during Follow-Up | 36 (4.9) | 7 (3.9) | 43 (4.7) | 0.696‡ |
| Experienced an IPT interruption of >2 months | 52 (7.1) | 30 (12.5) | 82 (8.4) | 0.010 |
| Current/Former Smoker | 112 (15.3) | 42 (17.4) | 154 (15.8) | 0.448 |
| Any Alcohol Use | 147 (20.1) | 57 (23.6) | 204 (20.9) | 0.250 |
†
P-value obtained from a two sample Wilcoxon rank-sum test
‡
P-value obtained from a Fisher’s exact test
*
7 individuals were missing WHO stage classification
**
5 individuals were missing ART eligibility because of missing CD4 cell counts and missing WHO stage